Parallel Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,324 shares of REGN stock, worth $929,249. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,324
Previous 1,251 5.84%
Holding current value
$929,249
Previous $1.31 Million 5.86%
% of portfolio
0.03%
Previous 0.03%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $74,758 - $87,728
73 Added 5.84%
1,324 $1.39 Million
Q2 2024

Aug 08, 2024
BUY
$883.2 - $1071.19 $88,320 - $107,119
100 Added 8.69%
1,251 $1.31 Million
Q1 2024

May 06, 2024
BUY
$902.69 - $993.35 $149,846 - $164,896
166 Added 16.85%
1,151 $1.11 Million
Q4 2023

Feb 09, 2024
SELL
$775.18 - $881.7 $486,813 - $553,707
-628 Reduced 38.93%
985 $865,000
Q3 2023

May 20, 2024
BUY
$692.45 - $844.37 $49,856 - $60,794
72 Added 4.67%
1,613 $1.33 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $49,856 - $60,794
72 Added 4.67%
1,613 $1.33 Million
Q2 2023

May 20, 2024
SELL
$700.03 - $830.35 $6,300 - $7,473
-9 Reduced 0.58%
1,541 $1.11 Million
Q2 2023

Aug 04, 2023
SELL
$700.03 - $830.35 $6,300 - $7,473
-9 Reduced 0.58%
1,541 $1.11 Million
Q1 2023

May 20, 2024
BUY
$680.49 - $826.97 $271,515 - $329,961
399 Added 34.67%
1,550 $1.27 Million
Q1 2023

Apr 25, 2023
SELL
$680.49 - $826.97 $40,829 - $49,618
-60 Reduced 3.73%
1,550 $1.27 Million
Q4 2022

Feb 03, 2023
SELL
$705.89 - $766.39 $72,706 - $78,938
-103 Reduced 6.01%
1,610 $1.16 Million
Q3 2022

Nov 10, 2022
SELL
$573.97 - $724.32 $75,764 - $95,610
-132 Reduced 7.15%
1,713 $1.18 Million
Q2 2022

Aug 01, 2022
BUY
$548.35 - $738.84 $433,196 - $583,683
790 Added 74.88%
1,845 $1.09 Million
Q1 2022

Apr 28, 2022
SELL
$595.12 - $698.43 $29,756 - $34,921
-50 Reduced 4.52%
1,055 $730,000
Q4 2021

Jan 20, 2022
BUY
$543.48 - $670.97 $34,239 - $42,271
63 Added 6.05%
1,105 $698,000
Q3 2021

Nov 02, 2021
BUY
$574.03 - $680.96 $253,147 - $300,303
441 Added 73.38%
1,042 $631,000
Q2 2021

Aug 06, 2021
BUY
$472.8 - $558.54 $45,861 - $54,178
97 Added 19.25%
601 $336,000
Q1 2021

Apr 23, 2021
SELL
$446.73 - $548.2 $86,218 - $105,802
-193 Reduced 27.69%
504 $238,000
Q4 2020

Feb 02, 2021
SELL
$478.3 - $607.98 $92,790 - $117,948
-194 Reduced 21.77%
697 $337,000
Q3 2020

Oct 27, 2020
BUY
$544.75 - $658.21 $128,561 - $155,337
236 Added 36.03%
891 $499,000
Q2 2020

Jul 16, 2020
BUY
$493.32 - $643.92 $49,825 - $65,035
101 Added 18.23%
655 $408,000
Q1 2020

Apr 27, 2020
BUY
$336.18 - $494.43 $68,244 - $100,369
203 Added 57.83%
554 $270,000
Q4 2019

Jan 30, 2020
BUY
$274.13 - $376.51 $20,011 - $27,485
73 Added 26.26%
351 $132,000
Q3 2019

Nov 01, 2019
SELL
$273.46 - $318.39 $14,219 - $16,556
-52 Reduced 15.76%
278 $77,000
Q2 2019

Aug 05, 2019
SELL
$299.6 - $414.82 $19,474 - $26,963
-65 Reduced 16.46%
330 $103,000
Q1 2019

May 01, 2019
BUY
$372.08 - $439.57 $9,302 - $10,989
25 Added 6.76%
395 $162,000
Q4 2018

Feb 05, 2019
SELL
$335.82 - $403.04 $33,246 - $39,900
-99 Reduced 21.11%
370 $138,000
Q3 2018

Nov 01, 2018
BUY
$351.14 - $408.51 $22,121 - $25,736
63 Added 15.52%
469 $189,000
Q2 2018

Jul 30, 2018
SELL
$284.6 - $344.99 $16,222 - $19,664
-57 Reduced 12.31%
406 $140,000
Q1 2018

May 08, 2018
SELL
$315.82 - $393.78 $12,001 - $14,963
-38 Reduced 7.58%
463 $159,000
Q4 2017

Feb 13, 2018
SELL
$358.63 - $469.95 $44,828 - $58,743
-125 Reduced 19.97%
501 $188,000
Q3 2017

Nov 15, 2017
BUY
$431.38 - $504.0 $270,043 - $315,504
626 New
626 $246,000
Q3 2017

Nov 14, 2017
SELL
$431.38 - $504.0 $280,828 - $328,104
-651 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
651
651 $320,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email